Global Parkinsons Disease Drug Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Parkinsons Disease Drug Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Parkinsons Disease Drug Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Carbidopa/Levodopa
1.2.3 Dopamine Receptor Agonists
1.2.4 MAO-Inhibitors
1.3 Market Segment by Application
1.3.1 Global Parkinsons Disease Drug Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Parkinsons Disease Drug Market Size (2017-2028)
2.1.1 Global Parkinsons Disease Drug Revenue (2017-2028)
2.1.2 Global Parkinsons Disease Drug Sales (2017-2028)
2.2 Global Parkinsons Disease Drug Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Parkinsons Disease Drug Sales by Regions (2017-2022)
2.2.2 Global Parkinsons Disease Drug Revenue by Regions (2017-2022)
2.3 Global Parkinsons Disease Drug Market Size Forecast by Region
2.3.1 Global Parkinsons Disease Drug Sales Forecast by Region (2023-2028)
2.3.2 Global Parkinsons Disease Drug Revenue Forecast by Region (2023-2028)
2.4 Global Top Parkinsons Disease Drug Regions (Countries) Ranking by Market Size
2.5 Parkinsons Disease Drug Market Dynamics
2.5.1 Parkinsons Disease Drug Market Trends
2.5.2 Parkinsons Disease Drug Market Drivers
2.5.3 Parkinsons Disease Drug Market Challenges
2.5.4 Parkinsons Disease Drug Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Parkinsons Disease Drug Manufacturers by Sales (2017-2022)
3.1.1 Global Parkinsons Disease Drug Sales by Manufacturers (2017-2022)
3.1.2 Global Parkinsons Disease Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Parkinsons Disease Drug Sales in 2021
3.2 Global Top Manufacturers Parkinsons Disease Drug by Revenue
3.2.1 Global Parkinsons Disease Drug Revenue by Manufacturers (2017-2022)
3.2.2 Top Parkinsons Disease Drug Manufacturers Covered: Ranking by Revenue
3.2.3 Global Parkinsons Disease Drug Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Parkinsons Disease Drug Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parkinsons Disease Drug as of 2021)
3.4 Global Parkinsons Disease Drug Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Parkinsons Disease Drug Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Parkinsons Disease Drug Market
3.7 Key Manufacturers Parkinsons Disease Drug Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Parkinsons Disease Drug Market Size by Type
4.1 Global Parkinsons Disease Drug Historic Market Review by Type (2017-2022)
4.1.1 Global Parkinsons Disease Drug Sales Market Share by Type (2017-2022)
4.1.2 Global Parkinsons Disease Drug Revenue Market Share by Type (2017-2022)
4.1.3 Parkinsons Disease Drug Price by Type (2017-2022)
4.2 Global Parkinsons Disease Drug Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Parkinsons Disease Drug Sales Forecast by Type (2023-2028)
4.2.2 Global Parkinsons Disease Drug Revenue Forecast by Type (2023-2028)
4.2.3 Parkinsons Disease Drug Price Forecast by Type (2023-2028)
5 Global Parkinsons Disease Drug Market Size by Application
5.1 Global Parkinsons Disease Drug Historic Market Review by Application (2017-2022)
5.1.1 Global Parkinsons Disease Drug Sales Market Share by Application (2017-2022)
5.1.2 Global Parkinsons Disease Drug Revenue Market Share by Application (2017-2022)
5.1.3 Parkinsons Disease Drug Price by Application (2017-2022)
5.2 Global Parkinsons Disease Drug Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Parkinsons Disease Drug Sales Forecast by Application (2023-2028)
5.2.2 Global Parkinsons Disease Drug Revenue Forecast by Application (2023-2028)
5.2.3 Parkinsons Disease Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Parkinsons Disease Drug Sales Breakdown by Company
6.1.1 North America Parkinsons Disease Drug Sales by Company (2017-2022)
6.1.2 North America Parkinsons Disease Drug Revenue by Company (2017-2022)
6.2 North America Parkinsons Disease Drug Market Size by Type
6.2.1 North America Parkinsons Disease Drug Sales by Type (2017-2028)
6.2.2 North America Parkinsons Disease Drug Revenue by Type (2017-2028)
6.3 North America Parkinsons Disease Drug Market Size by Application
6.3.1 North America Parkinsons Disease Drug Sales by Application (2017-2028)
6.3.2 North America Parkinsons Disease Drug Revenue by Application (2017-2028)
6.4 North America Parkinsons Disease Drug Market Size by Country
6.4.1 North America Parkinsons Disease Drug Sales by Country (2017-2028)
6.4.2 North America Parkinsons Disease Drug Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Parkinsons Disease Drug Sales Breakdown by Company
7.1.1 Europe Parkinsons Disease Drug Sales by Company (2017-2022)
7.1.2 Europe Parkinsons Disease Drug Revenue by Company (2017-2022)
7.2 Europe Parkinsons Disease Drug Market Size by Type
7.2.1 Europe Parkinsons Disease Drug Sales by Type (2017-2028)
7.2.2 Europe Parkinsons Disease Drug Revenue by Type (2017-2028)
7.3 Europe Parkinsons Disease Drug Market Size by Application
7.3.1 Europe Parkinsons Disease Drug Sales by Application (2017-2028)
7.3.2 Europe Parkinsons Disease Drug Revenue by Application (2017-2028)
7.4 Europe Parkinsons Disease Drug Market Size by Country
7.4.1 Europe Parkinsons Disease Drug Sales by Country (2017-2028)
7.4.2 Europe Parkinsons Disease Drug Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Parkinsons Disease Drug Sales Breakdown by Company
8.1.1 Asia Pacific Parkinsons Disease Drug Sales by Company (2017-2022)
8.1.2 Asia Pacific Parkinsons Disease Drug Revenue by Company (2017-2022)
8.2 Asia Pacific Parkinsons Disease Drug Market Size by Type
8.2.1 Asia Pacific Parkinsons Disease Drug Sales by Type (2017-2028)
8.2.2 Asia Pacific Parkinsons Disease Drug Revenue by Type (2017-2028)
8.3 Asia Pacific Parkinsons Disease Drug Market Size by Application
8.3.1 Asia Pacific Parkinsons Disease Drug Sales by Application (2017-2028)
8.3.2 Asia Pacific Parkinsons Disease Drug Revenue by Application (2017-2028)
8.4 Asia Pacific Parkinsons Disease Drug Market Size by Region
8.4.1 Asia Pacific Parkinsons Disease Drug Sales by Region
8.4.2 Asia Pacific Parkinsons Disease Drug Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Parkinsons Disease Drug Sales Breakdown by Company
9.1.1 Latin America Parkinsons Disease Drug Sales by Company (2017-2022)
9.1.2 Latin America Parkinsons Disease Drug Revenue by Company (2017-2022)
9.2 Latin America Parkinsons Disease Drug Market Size by Type
9.2.1 Latin America Parkinsons Disease Drug Sales by Type (2017-2028)
9.2.2 Latin America Parkinsons Disease Drug Revenue by Type (2017-2028)
9.3 Latin America Parkinsons Disease Drug Market Size by Application
9.3.1 Latin America Parkinsons Disease Drug Sales by Application (2017-2028)
9.3.2 Latin America Parkinsons Disease Drug Revenue by Application (2017-2028)
9.4 Latin America Parkinsons Disease Drug Market Size by Country
9.4.1 Latin America Parkinsons Disease Drug Sales by Country (2017-2028)
9.4.2 Latin America Parkinsons Disease Drug Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Parkinsons Disease Drug Sales Breakdown by Company
10.1.1 Middle East and Africa Parkinsons Disease Drug Sales by Company (2017-2022)
10.1.2 Middle East and Africa Parkinsons Disease Drug Revenue by Company (2017-2022)
10.2 Middle East and Africa Parkinsons Disease Drug Market Size by Type
10.2.1 Middle East and Africa Parkinsons Disease Drug Sales by Type (2017-2028)
10.2.2 Middle East and Africa Parkinsons Disease Drug Revenue by Type (2017-2028)
10.3 Middle East and Africa Parkinsons Disease Drug Market Size by Application
10.3.1 Middle East and Africa Parkinsons Disease Drug Sales by Application (2017-2028)
10.3.2 Middle East and Africa Parkinsons Disease Drug Revenue by Application (2017-2028)
10.4 Middle East and Africa Parkinsons Disease Drug Market Size by Country
10.4.1 Middle East and Africa Parkinsons Disease Drug Sales by Country (2017-2028)
10.4.2 Middle East and Africa Parkinsons Disease Drug Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Overview
11.1.3 Teva Parkinsons Disease Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Teva Parkinsons Disease Drug Products and Services
11.1.5 Teva Parkinsons Disease Drug SWOT Analysis
11.1.6 Teva Recent Developments
11.2 Novartis AG
11.2.1 Novartis AG Corporation Information
11.2.2 Novartis AG Overview
11.2.3 Novartis AG Parkinsons Disease Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Novartis AG Parkinsons Disease Drug Products and Services
11.2.5 Novartis AG Parkinsons Disease Drug SWOT Analysis
11.2.6 Novartis AG Recent Developments
11.3 GSK
11.3.1 GSK Corporation Information
11.3.2 GSK Overview
11.3.3 GSK Parkinsons Disease Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 GSK Parkinsons Disease Drug Products and Services
11.3.5 GSK Parkinsons Disease Drug SWOT Analysis
11.3.6 GSK Recent Developments
11.4 AbbVie
11.4.1 AbbVie Corporation Information
11.4.2 AbbVie Overview
11.4.3 AbbVie Parkinsons Disease Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 AbbVie Parkinsons Disease Drug Products and Services
11.4.5 AbbVie Parkinsons Disease Drug SWOT Analysis
11.4.6 AbbVie Recent Developments
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Overview
11.5.3 Merck Parkinsons Disease Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Merck Parkinsons Disease Drug Products and Services
11.5.5 Merck Parkinsons Disease Drug SWOT Analysis
11.5.6 Merck Recent Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Corporation Information
11.6.2 Boehringer Ingelheim Overview
11.6.3 Boehringer Ingelheim Parkinsons Disease Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Boehringer Ingelheim Parkinsons Disease Drug Products and Services
11.6.5 Boehringer Ingelheim Parkinsons Disease Drug SWOT Analysis
11.6.6 Boehringer Ingelheim Recent Developments
11.7 Impax Laboratories
11.7.1 Impax Laboratories Corporation Information
11.7.2 Impax Laboratories Overview
11.7.3 Impax Laboratories Parkinsons Disease Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Impax Laboratories Parkinsons Disease Drug Products and Services
11.7.5 Impax Laboratories Parkinsons Disease Drug SWOT Analysis
11.7.6 Impax Laboratories Recent Developments
11.8 Lundbeck
11.8.1 Lundbeck Corporation Information
11.8.2 Lundbeck Overview
11.8.3 Lundbeck Parkinsons Disease Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Lundbeck Parkinsons Disease Drug Products and Services
11.8.5 Lundbeck Parkinsons Disease Drug SWOT Analysis
11.8.6 Lundbeck Recent Developments
11.9 Sun Pharma
11.9.1 Sun Pharma Corporation Information
11.9.2 Sun Pharma Overview
11.9.3 Sun Pharma Parkinsons Disease Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Sun Pharma Parkinsons Disease Drug Products and Services
11.9.5 Sun Pharma Parkinsons Disease Drug SWOT Analysis
11.9.6 Sun Pharma Recent Developments
11.10 Wockhardt
11.10.1 Wockhardt Corporation Information
11.10.2 Wockhardt Overview
11.10.3 Wockhardt Parkinsons Disease Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Wockhardt Parkinsons Disease Drug Products and Services
11.10.5 Wockhardt Parkinsons Disease Drug SWOT Analysis
11.10.6 Wockhardt Recent Developments
11.11 UCB
11.11.1 UCB Corporation Information
11.11.2 UCB Overview
11.11.3 UCB Parkinsons Disease Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 UCB Parkinsons Disease Drug Products and Services
11.11.5 UCB Recent Developments
11.12 Bausch Health
11.12.1 Bausch Health Corporation Information
11.12.2 Bausch Health Overview
11.12.3 Bausch Health Parkinsons Disease Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.12.4 Bausch Health Parkinsons Disease Drug Products and Services
11.12.5 Bausch Health Recent Developments
11.13 Acadia
11.13.1 Acadia Corporation Information
11.13.2 Acadia Overview
11.13.3 Acadia Parkinsons Disease Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.13.4 Acadia Parkinsons Disease Drug Products and Services
11.13.5 Acadia Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Parkinsons Disease Drug Value Chain Analysis
12.2 Parkinsons Disease Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Parkinsons Disease Drug Production Mode & Process
12.4 Parkinsons Disease Drug Sales and Marketing
12.4.1 Parkinsons Disease Drug Sales Channels
12.4.2 Parkinsons Disease Drug Distributors
12.5 Parkinsons Disease Drug Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Parkinsons Disease Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Carbidopa/Levodopa
Table 3. Major Manufacturers of Dopamine Receptor Agonists
Table 4. Major Manufacturers of MAO-Inhibitors
Table 5. Global Parkinsons Disease Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Parkinsons Disease Drug Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Parkinsons Disease Drug Sales by Region (2017-2022) & (K Doses)
Table 8. Global Parkinsons Disease Drug Sales Market Share by Region (2017-2022)
Table 9. Global Parkinsons Disease Drug Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Parkinsons Disease Drug Revenue Market Share by Region (2017-2022)
Table 11. Global Parkinsons Disease Drug Sales Forecast by Region (2023-2028) & (K Doses)
Table 12. Global Parkinsons Disease Drug Sales Market Share Forecast by Region (2023-2028)
Table 13. Global Parkinsons Disease Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 14. Global Parkinsons Disease Drug Revenue Market Share Forecast by Region (2023-2028)
Table 15. Top Parkinsons Disease Drug Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 16. Parkinsons Disease Drug Market Trends
Table 17. Parkinsons Disease Drug Market Drivers
Table 18. Parkinsons Disease Drug Market Challenges
Table 19. Parkinsons Disease Drug Market Restraints
Table 20. Global Parkinsons Disease Drug Sales by Manufacturers (2017-2022) & (K Doses)
Table 21. Global Parkinsons Disease Drug Sales Share by Manufacturers (2017-2022)
Table 22. Global Parkinsons Disease Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Ranking of Global Top Parkinsons Disease Drug Manufacturers by Revenue (US$ Million) in 2021
Table 24. Parkinsons Disease Drug Revenue Share by Manufacturers (2017-2022)
Table 25. Global Parkinsons Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parkinsons Disease Drug as of 2021)
Table 27. Key Manufacturers Parkinsons Disease Drug Average Selling Price (ASP) & (2017-2022) & (USD/Dose)
Table 28. Key Manufacturers Parkinsons Disease Drug Plants/Factories Distribution
Table 29. Key Manufacturers Parkinsons Disease Drug Area Served
Table 30. Date of Key Manufacturers Enter into Parkinsons Disease Drug Market
Table 31. Key Manufacturers Parkinsons Disease Drug Product Type
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Parkinsons Disease Drug Sales (K Doses) by Type (2017-2022)
Table 34. Global Parkinsons Disease Drug Sales Share by Type (2017-2022)
Table 35. Global Parkinsons Disease Drug Revenue (US$ Million) Market Share by Type (2017-2022)
Table 36. Global Parkinsons Disease Drug Price (K Doses) by Type (2017-2022)
Table 37. Global Parkinsons Disease Drug Sales (K Doses) by Type (2023-2028)
Table 38. Global Parkinsons Disease Drug Sales Share by Type (2023-2028)
Table 39. Global Parkinsons Disease Drug Revenue (US$ Million) Market Share by Type (2023-2028)
Table 40. Global Parkinsons Disease Drug Revenue Share by Type (2023-2028)
Table 41. Global Parkinsons Disease Drug Price (K Doses) by Type (2023-2028)
Table 42. Global Parkinsons Disease Drug Sales (K Doses) by Application (2017-2022)
Table 43. Global Parkinsons Disease Drug Sales Share by Application (2017-2022)
Table 44. Global Parkinsons Disease Drug Revenue (US$ Million) Market Share by Application (2017-2022)
Table 45. Global Parkinsons Disease Drug Price (K Doses) by Application (2017-2022)
Table 46. Global Parkinsons Disease Drug Sales (K Doses) by Application (2023-2028)
Table 47. Global Parkinsons Disease Drug Sales Share by Application (2023-2028)
Table 48. Global Parkinsons Disease Drug Revenue (US$ Million) Market Share by Application (2023-2028)
Table 49. Global Parkinsons Disease Drug Revenue Share by Application (2023-2028)
Table 50. Global Parkinsons Disease Drug Price (K Doses) by Application (2023-2028)
Table 51. North America Parkinsons Disease Drug Sales by Company (2017-2022) & (K Doses)
Table 52. North America Parkinsons Disease Drug Sales Market Share by Company (2017-2022)
Table 53. North America Parkinsons Disease Drug Revenue by Company (2017-2022) & (US$ Million)
Table 54. North America Parkinsons Disease Drug Revenue Market Share by Company (2017-2022)
Table 55. North America Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 56. North America Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 57. North America Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
Table 58. North America Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
Table 59. North America Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 60. North America Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 61. North America Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
Table 62. North America Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
Table 63. North America Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 64. North America Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
Table 65. North America Parkinsons Disease Drug Revenue by Country (2017-2022) & (US$ Million)
Table 66. North America Parkinsons Disease Drug Revenue by Country (2023-2028) & (US$ Million)
Table 67. Europe Parkinsons Disease Drug Sales by Company (2017-2022) & (K Doses)
Table 68. Europe Parkinsons Disease Drug Sales Market Share by Company (2017-2022)
Table 69. Europe Parkinsons Disease Drug Revenue by Company (2017-2022) & (US$ Million)
Table 70. Europe Parkinsons Disease Drug Revenue Market Share by Company (2017-2022)
Table 71. Europe Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 72. Europe Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 73. Europe Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
Table 74. Europe Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
Table 75. Europe Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 76. Europe Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 77. Europe Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
Table 78. Europe Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
Table 79. Europe Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 80. Europe Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
Table 81. Europe Parkinsons Disease Drug Revenue by Country (2017-2022) & (US$ Million)
Table 82. Europe Parkinsons Disease Drug Revenue by Country (2023-2028) & (US$ Million)
Table 83. Asia Pacific Parkinsons Disease Drug Sales by Company (2017-2022) & (K Doses)
Table 84. Asia Pacific Parkinsons Disease Drug Sales Market Share by Company (2017-2022)
Table 85. Asia Pacific Parkinsons Disease Drug Revenue by Company (2017-2022) & (US$ Million)
Table 86. Asia Pacific Parkinsons Disease Drug Revenue Market Share by Company (2017-2022)
Table 87. Asia Pacific Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 88. Asia Pacific Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 89. Asia Pacific Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
Table 90. Asia Pacific Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
Table 91. Asia Pacific Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 92. Asia Pacific Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 93. Asia Pacific Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
Table 94. Asia Pacific Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
Table 95. Asia Pacific Parkinsons Disease Drug Sales by Region (2017-2022) & (K Doses)
Table 96. Asia Pacific Parkinsons Disease Drug Sales by Region (2023-2028) & (K Doses)
Table 97. Asia Pacific Parkinsons Disease Drug Revenue by Region (2017-2022) & (US$ Million)
Table 98. Asia Pacific Parkinsons Disease Drug Revenue by Region (2023-2028) & (US$ Million)
Table 99. Latin America Parkinsons Disease Drug Sales by Company (2017-2022) & (K Doses)
Table 100. Latin America Parkinsons Disease Drug Sales Market Share by Company (2017-2022)
Table 101. Latin America Parkinsons Disease Drug Revenue by Company (2017-2022) & (US$ Million)
Table 102. Latin America Parkinsons Disease Drug Revenue Market Share by Company (2017-2022)
Table 103. Latin America Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 104. Latin America Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 105. Latin America Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
Table 106. Latin America Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
Table 107. Latin America Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 108. Latin America Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 109. Latin America Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
Table 110. Latin America Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
Table 111. Latin America Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 112. Latin America Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
Table 113. Latin America Parkinsons Disease Drug Revenue by Country (2017-2022) & (US$ Million)
Table 114. Latin America Parkinsons Disease Drug Revenue by Country (2023-2028) & (US$ Million)
Table 115. Middle East and Africa Parkinsons Disease Drug Sales by Company (2017-2022) & (K Doses)
Table 116. Middle East and Africa Parkinsons Disease Drug Sales Market Share by Company (2017-2022)
Table 117. Middle East and Africa Parkinsons Disease Drug Revenue by Company (2017-2022) & (US$ Million)
Table 118. Middle East and Africa Parkinsons Disease Drug Revenue Market Share by Company (2017-2022)
Table 119. Middle East and Africa Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
Table 120. Middle East and Africa Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
Table 121. Middle East and Africa Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
Table 123. Middle East and Africa Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
Table 124. Middle East and Africa Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
Table 125. Middle East and Africa Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
Table 128. Middle East and Africa Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
Table 129. Middle East and Africa Parkinsons Disease Drug Revenue by Country (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Parkinsons Disease Drug Revenue by Country (2023-2028) & (US$ Million)
Table 131. Teva Corporation Information
Table 132. Teva Description and Overview
Table 133. Teva Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 134. Teva Parkinsons Disease Drug Product and Services
Table 135. Teva Parkinsons Disease Drug SWOT Analysis
Table 136. Teva Recent Developments
Table 137. Novartis AG Corporation Information
Table 138. Novartis AG Description and Overview
Table 139. Novartis AG Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 140. Novartis AG Parkinsons Disease Drug Product and Services
Table 141. Novartis AG Parkinsons Disease Drug SWOT Analysis
Table 142. Novartis AG Recent Developments
Table 143. GSK Corporation Information
Table 144. GSK Description and Overview
Table 145. GSK Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 146. GSK Parkinsons Disease Drug Product and Services
Table 147. GSK Parkinsons Disease Drug SWOT Analysis
Table 148. GSK Recent Developments
Table 149. AbbVie Corporation Information
Table 150. AbbVie Description and Overview
Table 151. AbbVie Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 152. AbbVie Parkinsons Disease Drug Product and Services
Table 153. AbbVie Parkinsons Disease Drug SWOT Analysis
Table 154. AbbVie Recent Developments
Table 155. Merck Corporation Information
Table 156. Merck Description and Overview
Table 157. Merck Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 158. Merck Parkinsons Disease Drug Product and Services
Table 159. Merck Parkinsons Disease Drug SWOT Analysis
Table 160. Merck Recent Developments
Table 161. Boehringer Ingelheim Corporation Information
Table 162. Boehringer Ingelheim Description and Overview
Table 163. Boehringer Ingelheim Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 164. Boehringer Ingelheim Parkinsons Disease Drug Product and Services
Table 165. Boehringer Ingelheim Parkinsons Disease Drug SWOT Analysis
Table 166. Boehringer Ingelheim Recent Developments
Table 167. Impax Laboratories Corporation Information
Table 168. Impax Laboratories Description and Overview
Table 169. Impax Laboratories Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 170. Impax Laboratories Parkinsons Disease Drug Product and Services
Table 171. Impax Laboratories Parkinsons Disease Drug SWOT Analysis
Table 172. Impax Laboratories Recent Developments
Table 173. Lundbeck Corporation Information
Table 174. Lundbeck Description and Overview
Table 175. Lundbeck Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 176. Lundbeck Parkinsons Disease Drug Product and Services
Table 177. Lundbeck Parkinsons Disease Drug SWOT Analysis
Table 178. Lundbeck Recent Developments
Table 179. Sun Pharma Corporation Information
Table 180. Sun Pharma Description and Overview
Table 181. Sun Pharma Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 182. Sun Pharma Parkinsons Disease Drug Product and Services
Table 183. Sun Pharma Parkinsons Disease Drug SWOT Analysis
Table 184. Sun Pharma Recent Developments
Table 185. Wockhardt Corporation Information
Table 186. Wockhardt Description and Overview
Table 187. Wockhardt Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 188. Wockhardt Parkinsons Disease Drug Product and Services
Table 189. Wockhardt Parkinsons Disease Drug SWOT Analysis
Table 190. Wockhardt Recent Developments
Table 191. UCB Corporation Information
Table 192. UCB Description and Overview
Table 193. UCB Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 194. UCB Parkinsons Disease Drug Product and Services
Table 195. UCB Recent Developments
Table 196. Bausch Health Corporation Information
Table 197. Bausch Health Description a

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs